Name | fidaxomicin |
---|---|
Synonyms |
lipiarmycin A3
clostomicin B1 (2R,3S,4S,5S,6R)-6-({(3E,5E,8S,9E,11S,12R,13E,15E,18S)-12-{[(2R,3S,4R,5S)-3,4-Dihydroxy-5-(isobutyryloxy)-6,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-11-ethyl-8-hydroxy-18-[(1R)-1-hydroxyethyl]-9,13,15-trimethyl-2-oxooxacyclooctadeca-3,5,9,13,15-pentaen-3-yl}methoxy)-4-hydroxy-5-methoxy-2-methyltetrahydro-2H-pyran-3-yl 3,5-dichloro-2-ethyl-4,6-dihydroxybenzoate (non-preferred name) Dificid Fidaxomicin tiacumicin B |
Description | Fidaxomicin(OPT-80; PAR-101) is a new class of narrow spectrum macrocyclic antibiotic drug; selective eradication of pathogenic Clostridium difficile with minimal disruption to the multiple species of bacteria that make up the normal, healthy intestinal flora. |
---|---|
Related Catalog | |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 1046.4±65.0 °C at 760 mmHg |
Molecular Formula | C52H74Cl2O18 |
Molecular Weight | 1058.039 |
Flash Point | 586.7±34.3 °C |
Exact Mass | 1056.425171 |
PSA | 266.66000 |
LogP | 10.73 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.590 |